Literature DB >> 6826714

Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.

W M Scheld, M A Sande.   

Abstract

A rabbit model of pneumococcal meningitis was used to examine the importance of bactericidal vs. bacteriostatic antimicrobial agents in the therapy of meningitis 112 animals were infected with one of two strains of type III Streptococcus pneumoniae. Both strains were exquisitely sensitive to ampicillin, minimum inhibitory concentration (MIC)/minimum bactericidal concentration (MBC)<0.125 mug/ml. The activity of chloramphenicol against the two strains varied: strain(1)-MIC 2 mug/ml, MBC 16 mug/ml; strain(2)-MIC 1 mug/ml, MBC 2 mug/ml. Animals were treated with either ampicillin or chloramphenicol in dosages that achieved a peak bactericidal effect in cerebrospinal fluid (CSF) for ampicillin against both strains. Two different dosages were used for chloramphenicol. The first dosage achieved a peak CSF concentration of 4.4+/-1.1 mug/ml that produced a bacteriostatic effect against strain(1) and bactericidal effect against strain(2). The second dosage achieved a bactericidal effect against both strains (mean peak CSF concentration 30.0 mug/ml). All animals were treated intramuscularly three times a day for 5 d. CSF was sampled daily and 3 d after discontinuation of therapy for quantitative bacterial cultures. Results demonstrate that only antimicrobial therapy that achieved a bactericidal effect in CSF was associated with cure. Over 90% of animals treated with one of the bactericidal regimens (i.e., animals in which the bacterial counts in CSF dropped >5 log(10) colony-forming units [cfu]/ ml after 48 h) had sterile CSF after 5 d of treatment. On the other hand, the regimen that achieved bacteriostatic concentrations (CSF drug concentrations between the MIC and MBC) produced a drop of 2.4 log(10) cfu/ml by 48 h; however, none of the animals that survived had sterile CSF after 5 d. These studies clearly demonstrate in a strictly controlled manner that maximally effective antimicrobial therapy of experimental pneumococcal meningitis depends on achieving a bactericidal effect in CSF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6826714      PMCID: PMC436888          DOI: 10.1172/jci110785

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Pneumonococcal meningitis-a killing disease.

Authors:  R H RISCHBIETH
Journal:  Med J Aust       Date:  1960-04-09       Impact factor: 7.738

2.  Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin.

Authors:  M H LEPPER; H F DOWLING
Journal:  AMA Arch Intern Med       Date:  1951-10

3.  Deficient cerebrospinal fluid opsonization in experimental Escherichia coli meningitis.

Authors:  L L Bernhardt; M S Simberkoff; J J Rahal
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

4.  Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone.

Authors:  W M Scheld; R G Dacey; H R Winn; J E Welsh; J A Jane; M A Sande
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

5.  Experimental pneumococcal meningitis I: a rabbit model.

Authors:  J M O'Donoghue; A I Schweid; H N Beaty
Journal:  Proc Soc Exp Biol Med       Date:  1974-06

6.  Antibiotic therapy of bacterial meningitis: lessons we've learned.

Authors:  M A Sande
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

7.  Leukocyte and bacterial interrelationships in experimental meningitis.

Authors:  C Giampaolo; M Scheld; J Boyd; J Savory; M Sande; M Wills
Journal:  Ann Neurol       Date:  1981-04       Impact factor: 10.422

8.  Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Authors:  R G Dacey; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

9.  Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.

Authors:  M A Sande; K B Courtney
Journal:  J Lab Clin Med       Date:  1976-07

10.  The role of opsonins in recovery from experimental pneumococcal pneumonia.

Authors:  J C Guckian; G D Christensen; D P Fine
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

View more
  31 in total

1.  Bacterial Meningitis: Principles and Practical Aspects of Therapy.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

2.  Noninvasive 11C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis.

Authors:  Elizabeth W Tucker; Beatriz Guglieri-Lopez; Alvaro A Ordonez; Brittaney Ritchie; Mariah H Klunk; Richa Sharma; Yong S Chang; Julian Sanchez-Bautista; Sarah Frey; Martin A Lodge; Steven P Rowe; Daniel P Holt; Jogarao V S Gobburu; Charles A Peloquin; William B Mathews; Robert F Dannals; Carlos A Pardo; Sujatha Kannan; Vijay D Ivaturi; Sanjay K Jain
Journal:  Sci Transl Med       Date:  2018-12-05       Impact factor: 17.956

Review 3.  Diagnosis and treatment of bacterial meningitis.

Authors:  H El Bashir; M Laundy; R Booy
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

Review 4.  Animal models as predictors of the safety and efficacy of antibiotics.

Authors:  O Zak; T O'Reilly
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-07       Impact factor: 3.267

5.  Acute Bacterial Meningitis: Challenges to Better Antibiotic Therapy.

Authors:  Colin Kietzman; Elaine Tuomanen
Journal:  ACS Infect Dis       Date:  2019-07-03       Impact factor: 5.084

6.  Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits.

Authors:  M G Täuber; S Kunz; O Zak; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

7.  Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3.

Authors:  P M Mendelman; J Campos; D O Chaffin; D A Serfass; A L Smith; J A Sáez-Nieto
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

8.  BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

Authors:  V Rodriguez-Cerrato; F Ghaffar; J Saavedra; I C Michelow; R D Hardy; J Iglehart; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.

Authors:  V Rodriguez-Cerrato; C C McCoig; I C Michelow; F Ghaffar; H S Jafri; R D Hardy; C Patel; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 10.  Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.

Authors:  Charles W Stratton
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.